A rating of 38 puts Immunoprecise Antibodies Ltd (IPA) near the middle of the Biotechnology industry according to InvestorsObserver. Immunoprecise Antibodies Ltd's score of 38 means it scores higher than 38% of stocks in the industry. Immunoprecise Antibodies Ltd also received an overall rating of 44, putting it above 44% of all stocks. Biotechnology is ranked 19 out of the 148 industries.
IPA has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on IPA!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 44 would rank higher than 44 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Immunoprecise Antibodies Ltd Stock Today?
Immunoprecise Antibodies Ltd (IPA) stock has fallen -2.76% while the S&P 500 has risen 0.01% as of 1:07 PM on Wednesday, Mar 20. IPA is lower by -$0.04 from the previous closing price of $1.45 on volume of 642,386 shares. Over the past year the S&P 500 has risen 29.39% while IPA is lower by -54.22%. IPA lost -$0.47 per share the over the last 12 months.
Click Here to get the full Stock Report for Immunoprecise Antibodies Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
